المؤلفون: Waizel M; Department of Ophthalmology, University of Basel, Mittlere Strasse 91, CH-4031, Basel, Switzerland. maria.waizel@usb.ch.; Knappschaft Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany. maria.waizel@usb.ch., Todorova MG; Department of Ophthalmology, University of Basel, Mittlere Strasse 91, CH-4031, Basel, Switzerland., Masyk M; Knappschaft Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany., Wolf K; Knappschaft Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany., Rickmann A; Knappschaft Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany., Helaiwa K; Knappschaft Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany.; University Eye Clinic Tuebingen, Centre for Ophthalmology, Tuebingen, Germany., Blanke BR; University Eye Clinic Tuebingen, Centre for Ophthalmology, Tuebingen, Germany., Szurman P; Knappschaft Eye Clinic Sulzbach, Knappschaft Hospital Saar, Sulzbach/Saar, Germany.; University Eye Clinic Tuebingen, Centre for Ophthalmology, Tuebingen, Germany.

المصدر: BMC ophthalmology [BMC Ophthalmol] 2017 May 23; Vol. 17 (1), pp. 79. Date of Electronic Publication: 2017 May 23.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Visual Acuity*, Bevacizumab/*administration & dosage , Ranibizumab/*administration & dosage , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage , Wet Macular Degeneration/*drug therapy, Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Drug Substitution ; Female ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Macula Lutea/pathology ; Male ; Middle Aged ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Retrospective Studies ; Tomography, Optical Coherence ; Treatment Outcome ; Wet Macular Degeneration/diagnosis

المؤلفون: Annekatrin Rickmann, Margarita G. Todorova, Peter Szurman, Maria della Volpe Waizel, Björn R. Blanke, Katharina Wolf, Michael Masyk, Khaled Helaiwa

المصدر: BMC Ophthalmology
BMC Ophthalmology, Vol 17, Iss 1, Pp 1-7 (2017)

مصطلحات موضوعية: 0301 basic medicine, Male, Visual acuity, genetic structures, Visual Acuity, Angiogenesis Inhibitors, chemistry.chemical_compound, 0302 clinical medicine, lcsh:Ophthalmology, Vascular endothelial growth factor a, Macula Lutea, Aflibercept, Aged, 80 and over, Drug Substitution, General Medicine, Middle Aged, Vascular endothelial growth factor, Bevacizumab, Treatment Outcome, Intravitreal Injections, Female, medicine.symptom, Tomography, Optical Coherence, medicine.drug, Research Article, medicine.medical_specialty, Recombinant Fusion Proteins, 03 medical and health sciences, Ophthalmology, Ranibizumab, medicine, Initial treatment, Humans, In patient, Aged, Retrospective Studies, business.industry, Macular degeneration, medicine.disease, eye diseases, Surgery, 030104 developmental biology, Receptors, Vascular Endothelial Growth Factor, chemistry, lcsh:RE1-994, 030221 ophthalmology & optometry, Wet Macular Degeneration, VEGF switch, sense organs, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fda0dec3d6823d449d60e8e1264f95d
https://pubmed.ncbi.nlm.nih.gov/28535756